RPRX
Royalty Pharma plc
$53.86
-$0.64(-1.17%)
71
Overall
100
Value
60
Tech
55
Quality
Market Cap
$16.52B
Volume
2.76M
52W Range
$32.21 - $54.64
Target Price
$59.57
Latest News for RPRX
Analysts’ Top Healthcare Picks: Amneal Pharmaceuticals (AMRX), Immunovant (IMVT)
Christine Brown•15 hours ago•May 26, 2026
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amneal Pharmaceuticals (AMRX), Immunovant (IMVT) and......
Bank of America Securities Keeps Their Buy Rating on Royalty Pharma (RPRX)
TipRanks Auto-Generated Intelligence Newsdesk•20 days ago•May 07, 2026
In a report released today, Jason Gerberry from Bank of America Securities maintained a Buy rating on Royalty Pharma, with a price target of $62.00......
News data is sourced from MarketXLS API and updated regularly.
Showing 2 of 2 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RPRX | $53.86 | -1.2% | 2.76M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |